The prevalence of the autoimmune markers in chronic hepatitis - C patients and their impact on treatment by interferon and clinical profile

Immunologic and Extra hepatic Manifestations of HCV Infection

Prevalence of thyroid dysfunction in Egyptianchronic hepatitis C patients treated with pegylated interferon and ribavirin

Diabetic chronic HCV patients and their response to interferon therapy

Study of insulin resistance (IR) as a predictor for response to interferon based therapy in patients with chronic HCV

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Serum hepcidin levels in chronic hepatitis C patients

Clinical biochemical and histological profile of chronic hepatitis c patients with normal serum aminotransferases

Islet cell antibodies and its relation to Diabetes mellitus in patients with chronic hepatitis B and C